NeoGenomics Inc (NEO)
Current ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 596,812 | 586,950 | 584,720 | 584,996 | 605,291 | 603,360 | 622,260 | 651,100 | 681,508 | 709,930 | 721,795 | 942,732 | 448,730 | 422,375 | 419,000 | 215,442 | 290,738 | 292,001 | 276,345 | 115,945 |
| Total current liabilities | US$ in thousands | 96,304 | 92,926 | 94,848 | 86,606 | 89,932 | 85,003 | 82,670 | 82,070 | 87,232 | 92,737 | 99,131 | 67,750 | 73,183 | 64,612 | 61,700 | 67,649 | 63,904 | 68,907 | 59,162 | 72,703 |
| Current ratio | 6.20 | 6.32 | 6.16 | 6.75 | 6.73 | 7.10 | 7.53 | 7.93 | 7.81 | 7.66 | 7.28 | 13.91 | 6.13 | 6.54 | 6.79 | 3.18 | 4.55 | 4.24 | 4.67 | 1.59 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $596,812K ÷ $96,304K
= 6.20
The current ratio of Neogenomics Inc. has shown a general decreasing trend over the past eight quarters, starting at 7.93 in Q1 2022 and gradually declining to 6.20 in Q4 2023. This ratio indicates that in Q4 2023, the company had $6.20 in current assets for every $1 in current liabilities.
Although the current ratio has decreased over time, Neogenomics Inc. has consistently maintained a healthy current ratio above 6, indicating a strong ability to cover its short-term obligations. This suggests that the company has a solid liquidity position and is less vulnerable to financial difficulties arising from short-term cash flow issues.
However, it is important to continue monitoring the trend of the current ratio to ensure that Neogenomics Inc. can efficiently manage its short-term financial obligations in the future.